We are live on ! Find out more
ORGO icon

Organogenesis Holdings

112 hedge funds and large institutions have $183M invested in Organogenesis Holdings in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 39

4% more capital invested

Capital invested by funds: $176M → $183M (+$6.94M)

0.83% more ownership

Funds ownership: 47.44%48.27% (+0.83%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

3% less funds holding

Funds holding: 115112 (-3)

96% less call options, than puts

Call options by funds: $3K | Put options by funds: $81K

Holders
112
Holders Change
-3
Holders Change %
-2.61%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
13
Increased
41
Reduced
39
Closed
14
Calls
$3K
Puts
$81K
Net Calls
-$78K
Net Calls Change
+$31K
Name Holding Trade Value Shares
Change
Change in
Stake
AB
101
Amalgamated Bank
New York
$7K
AAP
102
Arax Advisory Partners
Colorado
$6.61K
Federated Hermes
103
Federated Hermes
Pennsylvania
$4.6K +$452 +161 +11%
TWD
104
True Wealth Design
Ohio
$4.48K +$4.39K +1,565 New
PD
105
Point72 (DIFC)
United Arab Emirates
$3.77K +$3.7K +1,320 New
Comerica Bank
106
Comerica Bank
Texas
$3.66K
TFA
107
Toth Financial Advisory
Virginia
$2.86K
Allspring Global Investments
108
Allspring Global Investments
North Carolina
$1.63K -$42.4K -15,107 -96%
SCM
109
Sterling Capital Management
North Carolina
$609 +$597 +213 New
LC
110
Lindbrook Capital
California
$543 -$1.66K -591 -76%
S
111
SignatureFD
Georgia
$521 -$53 -19 -9%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
112
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.82M -649,900 Closed
Man Group
113
Man Group
United Kingdom
-$270K -96,416 Closed
CIS
114
Connors Investor Services
Pennsylvania
-$196K -70,000 Closed
Tudor Investment Corp
115
Tudor Investment Corp
Connecticut
-$170K -60,809 Closed
Principal Financial Group
116
Principal Financial Group
Iowa
-$107K -38,065 Closed
DWA
117
Delap Wealth Advisory
Oregon
-$39.9K -14,234 Closed
GCM
118
Gladius Capital Management
Illinois
-$32.6K -11,645 Closed
PAS
119
Point72 Asia (Singapore)
Singapore
-$31.9K -11,400 Closed
BCM
120
Bayesian Capital Management
New York
-$29.6K -10,584 Closed
Victory Capital Management
121
Victory Capital Management
Texas
-$28.1K -10,053 Closed
IC
122
Innealta Capital
Texas
-$19.2K -6,850 Closed
Russell Investments Group
123
Russell Investments Group
United Kingdom
-$18.3K -6,523 Closed
NC
124
nVerses Capital
Florida
-$16K -5,700 Closed
Simplex Trading
125
Simplex Trading
Illinois
-$5.11K -1,823 Closed

ORGO Hedge Fund Activity: Q3 2024 in Review

112 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2024, worth a combined $183M — up 3.9% from $176M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ORGO and 13 opened new positions — a net loss of 1 holder — while 39 trimmed existing stakes and 41 added.

The largest buyer was Deutsche Bank, adding an estimated $6.56M. The largest seller was Assenagon Asset Management, cutting an estimated $5.78M.

  • 112 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2024, down from 115 in Q2 2024.
  • Funds reported $183M of Organogenesis Holdings stock for Q3 2024, up 3.9% quarter-over-quarter.
  • 13 funds opened new Organogenesis Holdings positions in Q3 2024 and 14 closed out, a net change of -1 holder.
  • The largest Organogenesis Holdings buyer in Q3 2024 was Deutsche Bank, an estimated $6.56M added.
  • The largest Organogenesis Holdings seller in Q3 2024 was Assenagon Asset Management, an estimated $5.78M sold.

Based on aggregated 13F filings for Q3 2024.